Wall Street is agonizing over the triple threat that could bash through the U.S. economy
President Donald Trump’s election victory initially had the stock market in raptures . The S&P 500 surged 6.25% from Nov. 5 to Feb. 19, when the index hit a new record high above the $6,14...
AbbVie Joins Obesity Treatment Market With Up to $2.2B Licensing Deal
Key Takeaways AbbVie ( ABBV ) has agreed to license a weight-loss drug currently in development from Danish biotech firm Gubra for up to about $2.2 billion,...
Wedbush Calls Palantir a Top Stock to Own in 2025
Key Takeaways Wedbush analysts called Palantir ( PLTR ) one of their "top names to own in 2025." Shares of Palantir jumped over 6% in early trading Monda...
